Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon.

Narkewicz MR, Rosenthal P, Schwarz KB, Drack A, Margolis T, Repka MX; PEDS-C Study Group.

J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):183-6. doi: 10.1097/MPG.0b013e3181b99cf0.

2.

Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.

Kasahara A, Hiraide A, Tomita N, Iwahashi H, Imagawa A, Ohguro N, Yamamoto S, Mita E, Hayashi N.

J Gastroenterol. 2004 Nov;39(11):1106-9. Review.

PMID:
15580406
3.

Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

O'Day R, Gillies MC, Ahlenstiel G.

World J Gastroenterol. 2013 Dec 7;19(45):8227-37. doi: 10.3748/wjg.v19.i45.8227. Review.

4.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

Supplemental Content

Support Center